For the cancer-extrinsic roles of SUSD2 in the TME, it has been shown that SUSD2 can interact with interleukin-2 receptor (IL-2R) alpha and lead to the impairment of anti-tumor CD8+ T cell function [27]. This evidence concerns the gene CD8A and neoplasm.